Diagnos Laboratorium Utama Tbk. vs Rockfields Properti Indonesia Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp222 (market cap 308B, 129.6K 24h volume), while Rockfields Properti Indonesia Tbk. trades at Rp1,755 (market cap 2.55T, 7.4K 24h volume). The key difference: Rockfields Properti Indonesia Tbk. is far larger — about 8.3× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (129.6K versus 7.4K). Which is the better fit depends on your goals.
| DGNS | ROCK | |
|---|---|---|
Market Cap | 308B | 2.55T |
Volume | 129.6K | 7.4K |
Lot | 1.3K | 74 |
Turnover | 28.71M | 13.01M |
Average Price | 221.54 | 1,757.43 |
Value | 28.71M | 13.01M |
Indicative Equilibrium Price | 230 | 1,755 |
Indicative Equilibrium Volume | 110 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Rockfields Properti Indonesia, Tbk (formerly PT Nobel Properti Kencana) (“the Company” or “Holding Company”) was established in Republic of Indonesia based on the Notarial Deed No. 29 dated May 16, 2013 of Subiyanto Putro, S.H., M.Kn., Notary in Jakarta. The Company has commercially operated in April 2019.
Read more on ROCK →